Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-03-04Clinical Trial Update: A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
This phase I/II trial evaluated a combination of liposomal doxorubicin, melphalan, and bortezomib in relapsed/refractory multiple myeloma, b…
-
CLINICAL_TRIALS research · 2015-03-03Clinical Trial Update: Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma
A retrospective review of engraftment syndrome following autologous stem cell transplantation in patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2015-03-03Clinical Trial Update: Observational Study Evaluating the Potential Impact of Procalcitonin Testing on Care of Stemcell Transplant Recipients
An observational study update evaluating whether procalcitonin testing could impact the care of stem cell transplant recipients. The study, …
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization [NA]
This terminated study evaluated hyperbaric oxygen therapy plus standard growth factor support for hematopoietic progenitor/stem cell mobiliz…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Panobinostat/Velcade in Multiple Myeloma [Phase 1]
A phase 1 study evaluating panobinostat in combination with Velcade (bortezomib) for multiple myeloma was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy [Phase 3]
Phase 3 trial evaluated whether antibiotic therapy reduces early infections in patients with multiple myeloma undergoing chemotherapy; the s…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma [Phase 2]
A Phase 2 trial evaluating TBL12 Sea Cucumber Extract in untreated asymptomatic myeloma was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma [EARLY_Phase 1]
An EARLY Phase 1 clinical trial update reports on using filgrastim to treat patients with bortezomib-, carfilzomib-, or IMID-refractory mult…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma [Phase 1]
This Phase 1 trial evaluated the cardiac effects of siltuximab in patients with Monoclonal Gammopathy of Undetermined Significance and Multi…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Imaging in MGUS, SMM and MM [Phase 2]
Completed Phase 2 clinical trial evaluating imaging in monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 safety and PK/PD study of TG-0054 in patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease has completed with re…
-
CLINICAL_TRIALS research · 2015-01-13Clinical Trial Update: CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma [Phase 3]
A Phase 3 clinical trial is evaluating a CDD-based regimen with Bortezomib versus CDD alone in relapsed or refractory multiple myeloma with …
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen [Phase 1, Phase 2]
This completed Phase 1/2 clinical trial evaluated a conditioning regimen using Clofarabine and Busulfan for hematologic malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating bortezomib combined with liposomal doxorubicin, dexamethasone, and cyclophosphamide in multiple myeloma that relaps…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial update for SyB L-0501 in Relapsed/Refractory Multiple Myeloma; the study has completed and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease [Phase 2]
Phase 2 trial evaluating TG-0054 alone or with G-CSF in multiple myeloma and lymphomas; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: PAD. ICORG 05-01, V11 [Phase 2]
Phase 2 trial ICORG 05-01 for multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma [Phase 3]
Phase 3 companion study update for multiple myeloma trials, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Skin Biopsies in Chemotherapy-Induced Neuropathy
This completed clinical trial evaluated skin biopsies as a biomarker for chemotherapy-induced peripheral neuropathy in patients with multipl…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Quality of Life in Multiple Myeloma Patients Treated With Bortezomib
A completed clinical trial update examining quality of life in multiple myeloma patients treated with bortezomib.
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma [Phase 1]
Phase 1 trial update of vismodegib after stem cell transplant in high-risk or relapsed multiple myeloma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating SGN-40 (brentuximab vedotin) in patients with refractory or …
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen [Phase 2]
A Phase 2 trial assessing stem cell transplantation using a reduced-toxicity myeloablative conditioning regimen for high-risk multiple myelo…